| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
CEO And CMO | CEO And Chief Medical Officer | Chief Executive Officer +1 more
1 company
Thye Dirk serves as a CEO And CMO at QNCX. Across recent SEC filings that breaks down to 4 buys and 0 sells.
Historically, Thye Dirk's trades have earned a middling insider score of 52/100 across 4 rated trades. Over a 12-month horizon, 50.0% of those trades were profitable, with an average 12-month return of +28.1%.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Aug 30, 2024 | QNCX Quince Therapeutics, Inc. | CEO And Chief Medical Officer | Buy | 154,500 | $0.69 | $107,375.00 | +22.4% | +196.7% | +131.5% | |
| Aug 10, 2023 | QNCX Quince Therapeutics, Inc. | Chief Executive Officer | Buy | 88,000 | $1.26 | $110,880.00 | +24.4% | -23.4% | -44.4% | |
| Aug 8, 2023 | QNCX Quince Therapeutics, Inc. | Chief Executive Officer | Buy | 80,000 | $1.24 | $99,200.00 | +28.5% | -21.3% | -43.4% |